Enhancing discovery and treatment for
the myasthenia gravis patient community.
FEATURED
2026 Annual Report Spotlight
Discover how MGNet researchers, clinicians, patients, families, and advocacy partners are working together to advance research, improve care, and accelerate the development of new therapies for individuals living with myasthenia gravis.
Join One of Our Research Studies
Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by rare diseases
Find a StudyMGNet Announces 2026 Pilot Grant Award Recipient
The Myasthenia Gravis Rare Disease Network (MGNet) has awarded the 2026 MGNet Pilot Award to Marina Chiara Garassino, MD.
MGNet Announces 2026 Scholar
The Myasthenia Gravis Rare Disease Network (MGNet) has awarded the 2026 MGNet Scholar Award to Fatemeh Khani-Habibabadi, PhD.
Investigating the Impact of Demographic Trends on Disease Prognosis in Myasthenia Gravis
This study examines how changes in patient demographics over time influence disease prognosis and clinical outcomes in people with myasthenia gravis.
Learn More About Myasthenia Gravis
Access educational materials, frequently asked questions, lectures, and more.
MGNet Minute h2 >
Episode 1
Welcome to the MGNet Minute!
Episode 2
Know Your Antibody
Episode 3
Knowing Whether You’re Acetylcholine Receptor Antibody Positive
Episode 4
MuSK Antibody
MGNET Updates
MGNet Newsletter Consortium Updates
Learn More